Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析

◆英語タイトル:Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15489
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:87
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Smith & Nephew Plc (SN.) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for applications in orthopaedic reconstruction and trauma, sports medicine and advanced wound management. Its key offerings include hip and knee implants; products for correcting bone deformities and stabilizing severe fractures; sports medicine; products for repairing and removing soft tissues and advanced wound management products. The company offers its products to surgeons; nurses and nurse specialists; physicians and GPs; healthcare systems and procurement groups; payers and administrators; and retail consumers and patients across Europe, North America, Asia Pacific, the Middle East and Africa. Smith & Nephew is headquartered in London, the UK.

Smith & Nephew Plc Key Recent Developments

Mar 13,2019 Smith & Nephew to buy Osiris Therapeutics in $660m deal
Feb 20,2019 Smith & Nephew celebrates 18th year on FTSE4Good index
Feb 08,2019 Smith & Nephew: Directorate changes
Feb 07,2019 Smith & Nephew fourth quarter and full year 2018 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Smith & Nephew Plc – Key Facts
Smith & Nephew Plc – Key Employees
Smith & Nephew Plc – Key Employee Biographies
Smith & Nephew Plc – Major Products and Services
Smith & Nephew Plc – History
Smith & Nephew Plc – Company Statement
Smith & Nephew Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Smith & Nephew Plc – Business Description
Product Category: Advanced Wound Bioactives
Overview
Performance
Product Category: Advanced Wound Care
Overview
Performance
Product Category: Advanced Wound Devices
Overview
Performance
Product Category: Arthroscopic Enabling Technologies
Overview
Performance
Product Category: Hip Implants
Overview
Performance
Product Category: Knee Implants
Overview
Performance
Product Category: Other Surgical Businesses
Overview
Performance
Product Category: Sports Medicine Joint Repair
Overview
Performance
Product Category: Trauma & Extremities
Overview
Performance
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: Established Markets
Performance
Geographical Segment: Other Established Markets
Target Markets
R&D Overview
Smith & Nephew Plc – Corporate Strategy
Smith & Nephew Plc – SWOT Analysis
SWOT Analysis – Overview
Smith & Nephew Plc – Strengths
Smith & Nephew Plc – Weaknesses
Smith & Nephew Plc – Opportunities
Smith & Nephew Plc – Threats
Smith & Nephew Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Smith & Nephew Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Smith & Nephew Plc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Smith & Nephew Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 13, 2019: Smith & Nephew to buy Osiris Therapeutics in $660m deal
Feb 20, 2019: Smith & Nephew celebrates 18th year on FTSE4Good index
Feb 08, 2019: Smith & Nephew: Directorate changes
Feb 07, 2019: Smith & Nephew fourth quarter and full year 2018 results
Jan 18, 2019: The Steadman Clinic, SPRI and Smith & Nephew Host 13th Annual Vail Hip Symposium
Dec 13, 2018: Overland Park Surgical Suites first outpatient surgery center in region to offer robotics-assisted partial and total knee replacement surgery using the Navio surgical system
Nov 16, 2018: Smith & Nephew Presents Excellent Results for JOURNEY II Total Knee at the 2018 American Association of Hip and Knee Surgeons
Nov 01, 2018: Smith & Nephew third quarter 2018 trading report
Oct 17, 2018: Two new studies demonstrate INTERTAN Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures
Oct 16, 2018: Smith & Nephew launches PICO Y, the first portable single use negative pressure wound therapy system to treat two wounds simultaneously
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Smith & Nephew Plc, Key Facts
Smith & Nephew Plc, Key Employees
Smith & Nephew Plc, Key Employee Biographies
Smith & Nephew Plc, Major Products and Services
Smith & Nephew Plc, History
Smith & Nephew Plc, Subsidiaries
Smith & Nephew Plc, Joint Venture
Smith & Nephew Plc, Key Competitors
Smith & Nephew Plc, Ratios based on current share price
Smith & Nephew Plc, Annual Ratios
Smith & Nephew Plc, Annual Ratios (Cont...1)
Smith & Nephew Plc, Annual Ratios (Cont...2)
Smith & Nephew Plc, Interim Ratios
Smith & Nephew Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Smith & Nephew Plc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Smith & Nephew Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Smith & Nephew Plc, Performance Chart (2014 - 2018)
Smith & Nephew Plc, Ratio Charts
Smith & Nephew Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Smith & Nephew Plc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VeriFone Systems Inc:企業のM&A・事業提携・投資動向
    VeriFone Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VeriFone Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ck Hutchison Holdings Ltd
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vicat SA:企業の戦略・SWOT・財務情報
    Vicat SA - Strategy, SWOT and Corporate Finance Report Summary Vicat SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Dynapac Co., Ltd.:企業の戦略・SWOT・財務情報
    Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野:企業M&A・提携分析
    Summary Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742 …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Leap Therapeutics Inc (LPTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • NCC Group plc:企業の戦略・SWOT・財務分析
    NCC Group plc - Strategy, SWOT and Corporate Finance Report Summary NCC Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Symantec Corporation:企業の戦略・SWOT・財務情報
    Symantec Corporation - Strategy, SWOT and Corporate Finance Report Summary Symantec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments . The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems . Its products include sentinel 4DCT, catalyst H …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces n …
  • International Fibres Group Ltd:企業の戦略的SWOT分析
    International Fibres Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Flowserve Corporation:企業の戦略・SWOT・財務情報
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial …
  • NuvOx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NuvOx Pharma LLC (NuvOx Pharma) is a biotechnology company that develops oxygen therapeutics for the treatment of human diseases. The company develops novel therapies and formulations based on dodecafluoropentane emulsion platform. Its pipeline products include compounds such as NVX-108, NVX …
  • GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. G …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆